Development of a green QbD-based UV spectrophotometric method for simultaneous estimation of pazopanib and piroxicam in bulk and nanoformulation

The present study aimed to develop a green, Quality by Design (QbD)-assisted UV spectrophotometric method for the simultaneous estimation of pazopanib (PAZ) and piroxicam (PIR) in bulk drugs and liposomal nanoformulations, with potential application in monitoring stress-induced degradation. Simultaneous estimation of these drugs remains challenging due to the limited availability of simple, cost-effective, stability-monitoring, and environmentally sustainable analytical methods suitable for nanoformulation development and routine quality control, creating a need for robust AQbD-based analytical approaches. Furthermore, the lack of systematic QbD-based approaches necessitates the development of robust and reliable analytical procedures. An Analytical QbD approach employing face-centered central composite design was used to optimize critical analytical parameters and establish robust method conditions. The developed method was validated according to ICH Q2(R2) guidelines for selectivity, linearity, sensitivity, accuracy, precision, robustness, ruggedness, and repeatability. PAZ and PIR exhibited maximum absorbance at 271 nm and 331 nm, respectively, with excellent linearity over the concentration range of 2-10 μg/mL (R2 = 0.999). The method demonstrated good sensitivity, with limits of detection of 0.413 μg/mL for PAZ and 0.397 μg/mL for PIR, while limits of quantification were 1.253 μg/mL and 1.205 μg/mL, respectively. Recovery values ranged from 100.256 % to 101.676 %, and %RSD values below 2% confirmed the method’s accuracy and precision. Forced-degradation studies supported the potential applicability of the method for stability monitoring by demonstrating the degradation behavior of PAZ and PIR under different stress conditions. The validated method was successfully applied to PAZ-PIR-loaded liposomal formulations. Greenness assessment demonstrated excellent environmental sustainability. The developed AQbD-based UV spectrophotometric method provides a simple, robust, economical, and environmentally sustainable analytical platform for routine pharmaceutical quality control and PAZ-PIR liposomal nanoformulation development.

Authors

Publication Details

Journal
Figshare
Published
2026-11-12
DOI
https://doi.org/10.6084/m9.figshare.34992651
Primary Topic
Analytical Methods in Pharmaceuticals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of a green QbD-based UV spectrophotometric method for simultaneous estimation of pazopanib and piroxicam in bulk and nanoformulation

Rohan Singadi, Mitali Y Kubade, Priya M Patil, Suneel Dodamani et al.
Figshare
Analytical Methods in Pharmaceuticals
article

Development of a green QbD-based UV spectrophotometric method for simultaneous estimation of pazopanib and piroxicam in bulk and nanoformulation

Rohan Singadi, Mitali Y Kubade, Priya M Patil, Suneel Dodamani, Shourya Jadhav, Bhaskar Kurangi
article en

Abstract

The present study aimed to develop a green, Quality by Design (QbD)-assisted UV spectrophotometric method for the simultaneous estimation of pazopanib (PAZ) and piroxicam (PIR) in bulk drugs and liposomal nanoformulations, with potential application in monitoring stress-induced degradation. Simultaneous estimation of these drugs remains challenging due to the limited availability of simple, cost-effective, stability-monitoring, and environmentally sustainable analytical methods suitable for nanoformulation development and routine quality control, creating a need for robust AQbD-based analytical approaches. Furthermore, the lack of systematic QbD-based approaches necessitates the development of robust and reliable analytical procedures. An Analytical QbD approach employing face-centered central composite design was used to optimize critical analytical parameters and establish robust method conditions. The developed method was validated according to ICH Q2(R2) guidelines for selectivity, linearity, sensitivity, accuracy, precision, robustness, ruggedness, and repeatability. PAZ and PIR exhibited maximum absorbance at 271 nm and 331 nm, respectively, with excellent linearity over the concentration range of 2-10 μg/mL (R2 = 0.999). The method demonstrated good sensitivity, with limits of detection of 0.413 μg/mL for PAZ and 0.397 μg/mL for PIR, while limits of quantification were 1.253 μg/mL and 1.205 μg/mL, respectively. Recovery values ranged from 100.256 % to 101.676 %, and %RSD values below 2% confirmed the method’s accuracy and precision. Forced-degradation studies supported the potential applicability of the method for stability monitoring by demonstrating the degradation behavior of PAZ and PIR under different stress conditions. The validated method was successfully applied to PAZ-PIR-loaded liposomal formulations. Greenness assessment demonstrated excellent environmental sustainability. The developed AQbD-based UV spectrophotometric method provides a simple, robust, economical, and environmentally sustainable analytical platform for routine pharmaceutical quality control and PAZ-PIR liposomal nanoformulation development.

Figshare
Good health and well-being
Analytical Methods in Pharmaceuticals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon